Editas Medicine Inc (EDIT)
5.32
-0.24
(-4.32%)
USD |
NASDAQ |
May 10, 16:00
5.315
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Free Cash Flow: -151.03M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -151.03M |
| December 31, 2023 | -136.90M |
| September 30, 2023 | -156.25M |
| June 30, 2023 | -169.17M |
| March 31, 2023 | -167.60M |
| December 31, 2022 | -181.47M |
| September 30, 2022 | -176.00M |
| June 30, 2022 | -170.51M |
| March 31, 2022 | -173.69M |
| December 31, 2021 | -171.78M |
| September 30, 2021 | -175.83M |
| June 30, 2021 | -189.29M |
| March 31, 2021 | -180.33M |
| December 31, 2020 | -187.00M |
| September 30, 2020 | -106.20M |
| June 30, 2020 | -78.73M |
| March 31, 2020 | -73.35M |
| Date | Value |
|---|---|
| December 31, 2019 | -46.84M |
| September 30, 2019 | -86.26M |
| June 30, 2019 | -65.91M |
| March 31, 2019 | -56.71M |
| December 31, 2018 | -50.46M |
| September 30, 2018 | -75.73M |
| June 30, 2018 | -95.68M |
| March 31, 2018 | -104.08M |
| December 31, 2017 | -11.48M |
| September 30, 2017 | -0.471M |
| June 30, 2017 | 10.50M |
| March 31, 2017 | 25.97M |
| December 31, 2016 | -53.74M |
| September 30, 2016 | -47.80M |
| June 30, 2016 | -42.17M |
| March 31, 2016 | -11.20M |
| December 31, 2015 | -6.874M |
Free Cash Flow Range, Past 5 Years
-189.29M
Minimum
Jun 2021
-46.84M
Maximum
Dec 2019
-142.21M
Average
-168.38M
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.479B |
| Bristol-Myers Squibb Co | 12.51B |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Cabaletta Bio Inc | -54.24M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.87M |
| Cash from Investing (Quarterly) | -4.745M |
| Cash from Financing (Quarterly) | 0.192M |
| Free Cash Flow Per Share (Quarterly) | -0.6315 |
| Free Cash Flow to Equity (Quarterly) | -51.74M |
| Free Cash Flow Yield | -35.85% |